Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: Results of a randomized, double-blind, placebo- and active-controlled phase 2 trial

  • Calhoun D
  • White W
  • Krum H
 et al. 
  • 23

    Readers

    Mendeley users who have this article in their library.
  • 119

    Citations

    Citations of this article.

Abstract

LCI699, a novel inhibitor of aldosterone synthase, reduces serum aldosterone, and may have benefit in the treatment of hypertension.

Author-supplied keywords

  • blood pressure
  • hypertension
  • inhibitors
  • trials

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free